Journey Medical CorporationDERMNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank18
3Y CAGR-63.2%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-63.2%/yr
vs -39.3%/yr prior
Acceleration
-23.9pp
Decelerating
Percentile
P18
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$544000.00-94.5%
2024$9.86M+30.7%
2023$7.54M-31.1%
2022$10.94M-33.9%
2021$16.56M-
2020$0.00-
2019$0.00-100.0%
2018$80.55M-22.9%
2017$104.41M+25.5%
2016$83.17M-